Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

OBJECTIVE: The aim of this study was to assess the safety and efficacy of extending bevacizumab therapy beyond 15 months in nonprogressive ovarian cancer. PATIENTS AND METHODS: In this multinational prospective single-arm study (ClinicalTrials.gov NCT01239732), eligible patients had International Fe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Gynecol Cancer
Main Authors: Oza, Amit M., Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Ovarian Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5181120/
https://ncbi.nlm.nih.gov/pubmed/27749456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0000000000000836
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados